20.03.2025 10:25:00
|
5 Reasons It's Not Too Late to Buy Eli Lilly Stock
Eli Lilly (NYSE: LLY) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable healthcare company in the world, with a market cap of $730 billion.The next largest healthcare company is UnitedHealth Group, which is worth less than $450 billion. Over the past five years, Eli Lilly's stock has soared by around 530%, soundly beating the S&P 500 and its 136% gain during the same time frame.Even with such impressive gains in recent years, there is no shortage of reasons to feel comfortable buying and holding the stock for the long haul. Here are five of the best reasons to buy shares of Eli Lilly today and why it's not too late to add it to your portfolio.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
Analysen zu Eli Lillymehr Analysen
20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Eli Lilly | 778,20 | 1,62% |
|